Form 4: Prestige Consumer Healthcare Director Sells Shares
Insider Transaction Report
Prestige Consumer Healthcare Inc. Director John E. Byom sold 3,000 shares of common stock at $59.35 per share under a Rule 10b5-1 plan.
Summary
- John E. Byom, a Director of Prestige Consumer Healthcare Inc. (PBH), reported a sale of common stock.
- The transaction involved the disposition of 3,000 shares of common stock.
- The shares were sold at a price of $59.35 per share.
- The total value of the shares sold was $178,050.
- Following this transaction, John E. Byom beneficially owns 51,594 shares of common stock.
- The transaction was executed on November 25, 2025.
- The sale was made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. While it's an insider sale, the disclosure of a Rule 10b5-1 plan suggests a pre-planned, routine transaction for personal financial management rather than a reaction to negative company performance, mitigating potential negative interpretations.
Positives
- The transaction was conducted under a Rule 10b5-1 plan, indicating a pre-scheduled sale for personal financial planning or diversification rather than a reaction to recent company-specific news.
Negatives
- A director reducing their stake, even if planned, could be interpreted by some as a slight reduction in alignment with shareholder interests, though this is often a routine part of executive compensation and diversification.
Future Outlook
This filing does not contain any forward-looking statements or guidance.
Industry Context
This insider transaction is a routine disclosure and does not provide specific insights into broader industry trends or competitive landscape for the consumer healthcare sector.
Stakeholder Impact
- Shareholders: May observe a director's reduction in direct ownership, though the 10b5-1 plan suggests a non-event-driven sale.
Key Dates
| Date | Description |
|---|---|
| 11/25/2025 | Date of transaction (sale of common stock) |
| 11/26/2025 | Date the Form 4 was signed and filed |
Keywords
Prestige Consumer Healthcare, PBH, Insider Trading, Form 4, Stock Sale, Director, John E. Byom, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.